TEVA Stock Price, Chart, Stats & News

Teva Pharmaceutical Industries Limited
Save
39.85B
Market cap
11.68x
Current P/E
15.53x
Forward P/E
TEVA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 51.80% |
Operating margin | 12.49% |
Pretax margin | 7.17% |
Net margin | 8.16% |
Effective tax rate | -14.55% |
ROA | 3.46% |
ROE | 19.95% |
D/E | 2.20x |
Interest coverage ratio | 2.32x |
TEVA valuation
P/E | 11.68x |
P/S | 1.94x |
P/B | 4.17x |
P/CF | 20.03x |
P/FCF | 29.16x |
P/OCF | 20.03x |
PEG | 0.24x |
EV multiple | 6.22x |
About
Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical ointments, and creams. Additionally, Teva develops, produces, and sells active pharmaceutical ingredients (APIs).
Similar securities
Based on sector and market capitalization
Report issue











